10 Participants NeededMy employer runs this trial

Wireless Sensor for Premature Birth

AM
Overseen ByAlyssa Maximov
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

A wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.

Who Is on the Research Team?

GS

Guilherme Sant'Anna, MD, PhD

Principal Investigator

The Research Institute of the McGill University Health Center

Are You a Good Fit for This Trial?

This trial is for extremely premature newborns in the NICU who need close monitoring of their vital signs, such as heart rate and oxygen levels. Babies with certain health conditions or complications may not be eligible.

Inclusion Criteria

Neonatal Nurse Practitioner and Healthcare Team in agreement for the patient to participate in the study
My infant is clinically stable.
I am an infant older than 72 hours.
See 1 more

Exclusion Criteria

My infant has a skin condition that could make injury more likely.
Neonatal Nurse Practitioner/Healthcare Team in disagreement for the patient to participate in the study
My baby was born before 22 weeks or after 29 weeks and 6 days of pregnancy.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Wireless MicroPremVitals Button Sensor System

Trial Overview

The study is testing a new wireless, miniaturized sensor system called MicroPremVitals Button Sensors to monitor vital signs like ECG, oxygen saturation, and skin temperature in preterm infants.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Micro Preterm InfantExperimental Treatment1 Intervention
Group II: Extremely Preterm InfantExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Recruited
170,000+

Northwestern Querrey Simpson Institute for Bioelectronics (QSIB)

Collaborator